Paul Harch

An Emergency Medicine and Hyperbaric Medicine clinician, Paul Harch is a Clinical Professor of Medicine, Section of Emergency Medicine, at LSU School of Medicine in New Orleans, and former director of the University Medical Center Hyperbaric Medicine Department and LSU Hyperbaric Medicine Fellowship.

In 1989, he adapted concepts of conventional hyperbaric oxygen therapy (HBOT) to treat and conduct research on patients with wounds in the central nervous system. That initiative resulted in a private practice with one of the largest and most diverse case experiences in neurological hyperbaric medicine in the world.

In March 2020, Dr. Harch proposed the use of HBOT to treat COVID-19 pneumonia based on similar and successful use in 1918 for patients dying of Spanish Flu. Dr. Harch has now successfully treated patients with long COVID-19 and COVID vaccine injuries.

His work and perspectives on hyperbaric oxygen therapy have been published in multiple scientific articles, book chapters, and in his book, “The Oxygen Revolution”, where HBOT is explained as an epigenetic therapy with expected revolutionary effects on medicine and neurology.